340B Drug Pricing Program: Recent Developments
Foley & Lardner
April 18, 2013
2 pages
Trending ..... Myriad: SCOTUS Rules on Gene Patentability ..... Oxford Health Plans: SCOTUS Backs Arbitrator on Class Call ..... Bowman v. Monsanto: SCOTUS on Self-Replicating Technologies (eg Seeds) ..... SEC Proposes Money Market Reforms ..... Wellness Program Guidance ..... Equator Principles ..... Broker-Dealer Faces FCPA, Travel Act and Securities Fraud Charges for Venezuelan Payments ..... NLRB's Employee Rights Poster Comes Down ..... Ralph Lauren Settles FCPA Charges ..... Kiobel: SCOTUS Sends Alien Tort Statute Packing ..... DoJ Cuts Corporate Plea Agreement Carve-Out ..... How Bad Will it Be? That is Sequestration ..... HIPAA Omnibus Rule ..... Final FATCA Regs ..... PPACA: Play or Pay ..... DOJ/SEC Issue FCPA Guidance .....
340B Drug Pricing Program: Recent Developments
Foley & Lardner
April 18, 2013
2 pages
340B Program GPO Prohibition Compliance Extension
McDermott Will & Emery
April 8, 2013
1 page
340B Drug Pricing Program Notices on Group Purchasing Organizations and Medicaid Exclusion File
McDermott Will & Emery
March 27, 2013
2 pages
The Pressure Is On For 340B Entities
Mintz Levin
From Law360
March 4, 2013
5 pages
What Drug Manufacturers Need to Know About 340B in 2013
Covington & Burling
February 21, 2013
3 pages
Fulbright & Jaworski
February 20, 2013
2 pages
Three Steps to Prepare for a 340B Integrity Audit
McguireWoods
January 11, 2013
2 pages
340B-Covered Entity Recertification Coming January 2013
McGuireWoods
November 14, 2012
2 pages
Increased Scrutiny of 340B Drug Pricing Program Compliance and Enforcement
Foley & Lardner
May 30, 2012
3 pages